chr17-31304601-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006495.4(EVI2B):āc.1009G>Cā(p.Asp337His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000103 in 1,614,108 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006495.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EVI2B | NM_006495.4 | c.1009G>C | p.Asp337His | missense_variant | 2/2 | ENST00000330927.5 | NP_006486.3 | |
NF1 | NM_001042492.3 | c.4836-21219C>G | intron_variant | ENST00000358273.9 | NP_001035957.1 | |||
NF1 | NM_000267.3 | c.4773-21219C>G | intron_variant | NP_000258.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EVI2B | ENST00000330927.5 | c.1009G>C | p.Asp337His | missense_variant | 2/2 | 1 | NM_006495.4 | ENSP00000333779.4 | ||
NF1 | ENST00000358273.9 | c.4836-21219C>G | intron_variant | 1 | NM_001042492.3 | ENSP00000351015.4 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000123 AC: 31AN: 251034Hom.: 0 AF XY: 0.000184 AC XY: 25AN XY: 135666
GnomAD4 exome AF: 0.000107 AC: 156AN: 1461832Hom.: 0 Cov.: 32 AF XY: 0.000136 AC XY: 99AN XY: 727210
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152276Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74456
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 28, 2022 | The c.1009G>C (p.D337H) alteration is located in exon 2 (coding exon 1) of the EVI2B gene. This alteration results from a G to C substitution at nucleotide position 1009, causing the aspartic acid (D) at amino acid position 337 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at